Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 150 Squamous Cell Carcinoma of Head and Neck 76 Head and Neck Neoplasms 75 Stomach Neoplasms 52 Lung Neoplasms 52 Esophageal Neoplasms 34 Neoplasms 33 Uterine Cervical Neoplasms 32 Urinary Bladder Neoplasms 32 Carcinoma, Squamous Cell 27 Parkinson Disease 4, Autosomal Dominant Lewy Body 26 Neoplasm Metastasis 26 Small Cell Lung Carcinoma 23 Breast Neoplasms 23 Cholangiocarcinoma 21 Carcinoma 19 Ovarian Neoplasms 14 Adenocarcinoma Of Esophagus 14 Triple Negative Breast Neoplasms 13 Pancreatic Neoplasms 13 Oropharyngeal Neoplasms 13 Mesothelioma, Malignant 13 Adenocarcinoma 13 Biliary Tract Neoplasms 12 Mesothelioma 11 Gallbladder Neoplasms 11 Esophageal Squamous Cell Carcinoma 10 Carcinoma, Transitional Cell 10 Tongue Neoplasms 9 Laryngeal Neoplasms 9

Interventions

Nivolumab 5 Ipilimumab 3 relatlimab 1 daratumumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Various Advanced Cancer × Cisplatin × Clear all

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡